I'm not going into detail on Geron suing Viacyte over patent infringement. It looks like Geron may win. The lawyer at Geron buys 50,000 shares in early Oct. Indicates that the case is going in Geron favor.
Remember the new CEO who has a history of selling to big pharma every time he takes over a new company.
The European court ruling today, Geron benefits with other U.S. based stem cell companies.
Geron price rises and or Geron gets bought out, not the whole company but pieces.
Will be buying more shares and selling cover calls on any price spike. Also will sell a few shares on any price spike.
No comments:
Post a Comment